Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 23, Issue 11, 2008, Pages 3685-3689

  Chiu, Yen Ling ^a,b   Chen, Hung Yuan ^a,b   Chuang, Yi Fang ^c   Hsu, Shih Ping ^a,b   Lai, Chun Fu ^a,b   Pai, Mei Fen ^a,b   Yang, Shao Yo ^a,b   Peng, Yu Sen ^a,b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c MIN SHENG GENERAL HOSPITAL   (Taiwan)

Author keywords

Hepatitis C; Inflammation; Uraemic pruritus

Indexed keywords

ANTIHISTAMINIC AGENT; C REACTIVE PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEPHRITIS; PATHOGENESIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; UREMIC PRURITUS; VISUAL ANALOG SCALE;

AGED; C-REACTIVE PROTEIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PRURITUS; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; UREMIA;

EID: 54149117849     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn303     Document Type: Article

References (34)

1. Pisoni RL, Wikstrom B, Elder SJ et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006; 21: 3495-3505
2. Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis 2007; 50: 11-20
3. Morton CA, Lafferty M, Hau C et al. Pruritus and skin hydration during dialysis. Nephrol Dial Transplant 1996; 11: 2031-2036
4. Katz AI, Hampers CL, Merrill JP. Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy. Medicine (Baltimore) 1969; 48: 333-374
5. Noordzij M, Boeschoten EW, Bos WJ et al. Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. Nephrol Dial Transplant 2007; 22: 2944-2949
6. Valsecchi R, Cainelli T. Generalized pruritus: a manifestation of iron deficiency. Arch Dermatol 1983; 119: 630
7. Peer G, Kivity S, Agami O et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996; 348: 1552-1554
8. Zakrzewska-Pniewska B, Jedras M. Is pruritus in chronic uremic patients related to peripheral somatic and autonomic neuropathy? Study by R-R interval variation test (RRIV) and by sympathetic skin response (SSR). Neurophysiol Clin 2001; 31: 181-193
9. Reiz S, Westberg M. Side-effects of epidural morphine. Lancet 1980; 2: 203-204
10. Bergasa NV, Alling DW, Talbot TL et al. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med 1995; 123: 161-167
11. Pauli-Magnus C, Mikus G, Alscher DM et al. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol 2000; 11: 514-519
12. Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus - new perspectives and insights from recent trials. Nephrol Dial Transplant 2002; 17: 1558-1563
13. Virga G, Visentin I, La Milia V et al. Inflammation and pruritus in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 2164-2169
14. Kimmel M, Alscher DM, Dunst R et al. The role of microinflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 2006; 21: 749-755
15. Tsirpanlis G, Bagos P, Ioannou D et al. The variability and accurate assessment of microinflammation in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 150-157
16. Papanicolaou DA, Vgontzas AN. Interleukin-6: the endocrine cytokine. J Clin Endocrinol Metab 2000; 85: 1331-1333
17. Honda H, Qureshi AR, Heimburger O et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-148
18. Wahlgren CF, Tengvall Linder M, Hagermark O et al. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res 1995; 287: 572-580
19. Gaspari AA, Lotze MT, Rosenberg SA et al. Dermatologic changes associated with interleukin 2 administration. JAMA 1987; 258: 1624-1629
20. Garssen J, Vandebriel RJ, De Gruijl FR et al. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology 1999; 97: 506-514
21. Silva SR, Viana PC, Lugon NV et al. Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron 1994; 67: 270-273
22. Fusaro M, Munaretto G, Spinello M et al. Regression of uraemic pruritus by cyclosporin treatment in a haemodialysis patient. Nephrol Dial Transplant 2004; 19: 1338-1339
23. Narita I, Alchi B, Omori K et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 2006; 69: 1626-1632
24. Hung KY, Shyu RS, Tsai TJ et al. Viral hepatitis infection should be considered for evaluating uremic pruritus in continuous ambulatory peritoneal dialysis patients. Blood Purif 1998; 16: 147-153
25. Dyachenko P, Shustak A, Rozenman D. Hemodialysis-related pruritus and associated cutaneous manifestations. Int J Dermatol 2006; 45: 664-667
26. Pawlak K, Pawlak D, Mysliwiec M. Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients. Cytokine 2004; 28: 197-204
27. Peer G, Kivity S, Agami O et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996; 348: 1552-1554
28. Floris-Moore M, Howard AA, Lo Y et al. Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS 2007; 21: 479-491
29. Nascimento MM, Bruchfeld A, Suliman ME et al. Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients. Braz J Med Biol Res 2005; 38: 783-788
30. Hinrichsen H, Leimenstoll G, Stegen G et al. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut 2002; 51: 429-433
31. Kleeman CR, Massry SG, Popovtzer MM et al. The disappearance of intractable pruritus after parathyroidectomy in uremic patients with secondary hyperparathyroidism. Trans Assoc Am Physicians 1968; 81: 203-212
32. Johansson O, Hilliges M, Han SW et al. Immunohistochemical screening for neurochemical markers in uremic patients on maintenance hemodialysis. Skin Pharmacol 1988; 1: 265-268
33. Stahle-Backdahl M, Hagermark O, Lins LE et al. Experimental and immunohistochemical studies on the possible role of parathyroid hormone in uraemic pruritus. J Intern Med 1989; 225: 411-415
34. Zucker I, Yosipovitch G, David M et al. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol 2003; 49: 842-846